Muhammad Panezai, MD

Transplant Nephrologist
  • Position: Transplant Nephrologist
  • Primary Specialty: Nephrology
  • Additional Specialty: Transplant
  • Languages Spoken: English, Hindi, Urdu, Pashto
  • Gender: Male

About Muhammad Panezai

Muhammad Ajmal Khan Panezai is a board-certified Transplant Nephrologist currently serving at the OU Health Transplant Institute. He holds board certifications from the American Board of Internal Medicine (ABIM) in Internal Medicine and Nephrology, as well as the American Hypertension Specialist Certification. In 2024, he completed a Certification in Physician Leadership from the American College of Physicians (ACP) and the American Association for Physician Leadership (AAPL).

Dr. Panezai's advanced training includes a Transplant Nephrology Fellowship at Indiana University School of Medicine, a Nephrology Fellowship at Baylor University Medical Center in Dallas, TX, and an Internal Medicine Residency at Interfaith Medical Center. His professional experience encompasses roles as a Transplant Nephrologist at NZTI Transplant Institute, Nephrologist at Oklahoma City VA Health Care System, and Hospitalist at Integris Baptist Medical Center.

Fluent in English, Pashto, Urdu, and Hindi, Dr. Panezai has diverse interests outside of medicine, including Bitcoin and cryptocurrency, politics, and cricket.
Affiliations OU Health Transplant Center
Health Education
  • Medical School
  • Doctor of Medicine Bolan University of Medical & Health Sciences
    Quetta
  • Residency
  • Internal Medicine Interfaith Medical Center
    Brooklyn, NY
  • Fellowship
  • Nephrology Baylor University Medical Center
    Dallas, TX
  • Transplant Nephrology Indiana University School of Medicine
    Indianapolis, IN
Medical Interests Areas of Interest:
  • ABG
  • Central Line Insertion & Management
  • Endotracheal Intubation
  • Kidney Biopsy (Native and Allograft)
  • Knee Arthrocentesis
  • Lumbar Puncture
  • Paracentesis
  • Quinton (Temporary Dialysis Catheter) Insertion
  • Thoracentesis
Star Ratings
Comments